RT Journal Article
SR Electronic
T1 Reduced Pediatric Urgent Asthma Utilization and Exacerbations During the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.28.21256263
DO 10.1101/2021.04.28.21256263
A1 Jillian H. Hurst
A1 Congwen Zhao
A1 Nicholas S. Fitzpatrick
A1 Benjamin A. Goldstein
A1 Jason E. Lang
YR 2021
UL http://medrxiv.org/content/early/2021/05/01/2021.04.28.21256263.abstract
AB Background and Objectives The COVID-19 pandemic has had a profound impact on healthcare access and utilization, which could have important implications for children with chronic diseases, including asthma. We sought to evaluate changes in healthcare utilization and outcomes in children with asthma during the COVID-19 pandemic.Methods We used electronic health records data to evaluate healthcare use and asthma outcomes in 3,959 children and adolescents, 5-17 years of age, with a prior diagnosis of asthma who had a history of well child visits and encounters within the healthcare system. We assessed all-cause healthcare encounters and asthma exacerbations in the 12-months preceding the start of the COVID-19 pandemic (March 1, 2019 – February 29, 2020) and the first 12-months of the pandemic (March 1, 2020 – February 28, 2021).Results All-cause healthcare encounters decreased significantly during the pandemic compared to the preceding year, including well child visits (48.1% during the pandemic vs. 66.6% in the prior year; p < 0.01), emergency department visits (9.7% vs. 21.0%; p < 0.01), and inpatient admissions (1.6% vs. 2.5%; p < 0.01), though there was over a 100-fold increase in telehealth encounters. Asthma exacerbations that required treatment with systemic steroids also decreased (127 vs. 504 exacerbations; p < 0.01). Race/ethnicity was not associated with changes in healthcare utilization or asthma outcomes.Conclusion The COVID-19 pandemic corresponded to dramatic shifts in healthcare utilization, including increased telehealth use and improved outcomes among children with asthma. Social distancing measures may have also reduced asthma trigger exposure.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was a retrospective data analysis.Funding StatementFunded by a grant from the National Heart, Lung, and Blood Institute (5R21HL145415-02, JEL/BAG) and by the Duke Children’s Health & Discovery Initiative. The project was supported by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through Grant Award Number UL1TR001117 at Duke University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was evaluated by the Duke University Health System (DUHS) Institutional Review Board (Pro00091342).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified analytic sets will be provided upon request to the authors.